Aceto Corporation Company Profile (NASDAQ:ACET)

About Aceto Corporation

Aceto Corporation logoAceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Chemicals - Major Diversified
  • Sub-Industry: Trading Companies & Distributors
  • Exchange: NASDAQ
  • Symbol: ACET
  • CUSIP: 00444610
Key Metrics:
  • Previous Close: $15.45
  • 50 Day Moving Average: $18.04
  • 200 Day Moving Average: $19.71
  • 52-Week Range: $30,113,000.00 - $14.67
  • Trailing P/E Ratio: 21.76
  • Foreward P/E Ratio: 7.80
  • P/E Growth: 1.03
  • Market Cap: $462.54M
  • Outstanding Shares: 30,113,000
  • Beta: 1.5
  • Net Margins: 3.84%
  • Return on Equity: 11.70%
  • Return on Assets: 5.73%
  • Debt-to-Equity Ratio: 0.93%
  • Current Ratio: 2.21%
  • Quick Ratio: 1.52%
Additional Links:
Companies Related to Aceto Corporation:

Analyst Ratings

Consensus Ratings for Aceto Corporation (NASDAQ:ACET) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $21.00 (36.72% upside)

Analysts' Ratings History for Aceto Corporation (NASDAQ:ACET)
DateFirmActionRatingPrice TargetDetails
2/3/2017Craig HallumDowngradeBuy -> HoldView Rating Details
1/31/2017First AnalysisDowngradeOverweight -> Equal WeightView Rating Details
(Data available from 2/26/2015 forward)


Earnings History for Aceto Corporation (NASDAQ:ACET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/2/2017Q2 2017$0.32$0.24$136.65 million$125.60 millionViewListenView Earnings Details
11/4/2016Q1 17$0.29$0.28$132.88 million$128.02 millionViewListenView Earnings Details
8/25/2016Q416$0.39$0.35$146.71 million$135.40 millionViewListenView Earnings Details
5/5/2016Q3$0.39$0.42$150.07 million$157.90 millionViewListenView Earnings Details
2/4/2016Q2$0.30$0.36$132.71 million$131.70 millionViewListenView Earnings Details
11/5/2015Q116$0.34$0.37$139.89 million$133.50 millionViewListenView Earnings Details
9/10/2015Q415$0.31$0.48$146.68 million$146.60 millionViewListenView Earnings Details
5/7/2015Q3$0.29$0.34$140.00 million$145.80 millionViewListenView Earnings Details
2/5/2015Q115$0.26$0.28$130.00 million$13.00 millionViewListenView Earnings Details
11/6/2014Q414$0.29$0.23$146.40 million$130.80 millionViewListenView Earnings Details
9/4/2014Q314$0.17$0.21$134.23 million$139.60 millionViewListenView Earnings Details
5/8/2014Q214$0.28$0.19$136.70 million$124.83 millionViewListenView Earnings Details
2/7/2014Q114$0.24$0.24$147.02 million$116.50 millionViewListenView Earnings Details
8/28/2013Q4 2013$0.20$0.19$113.10 million$123.10 millionViewListenView Earnings Details
5/9/2013Q3 2013$0.26$0.34$128.56 million$150.90 millionViewListenView Earnings Details
11/8/2012Q113$0.19$0.18$110.85 million$111.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aceto Corporation (NASDAQ:ACET)
Current Year EPS Consensus Estimate: $1.50 EPS
Next Year EPS Consensus Estimate: $1.97 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.35$0.40$0.37
Q2 20162$0.39$0.42$0.41
Q3 20161$0.39$0.39$0.39
Q4 20162$0.36$0.37$0.37
Q1 20172$0.29$0.29$0.29
Q2 20172$0.27$0.42$0.35
Q3 20172$0.39$0.47$0.43
Q4 20172$0.37$0.59$0.48
Q1 20181$0.49$0.49$0.49
Q2 20181$0.51$0.51$0.51
(Data provided by Zacks Investment Research)


Current Dividend Information for Aceto Corporation (NASDAQ:ACET)
Annual Dividend:$0.26
Dividend Yield:1.69%
Payout Ratio:36.62% (Based on Trailing 12 Months of Earnings)
17.33% (Based on Current Year Consensus EPS Estimate)
13.20% (Based on Next Year Consensus EPS Estimate)

Dividend History for Aceto Corporation (NASDAQ:ACET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Aceto Corporation (NASDAQ:ACET)
Insider Ownership Percentage: 4.10%
Institutional Ownership Percentage: 85.95%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/17/2017Daniel B YaroshDirectorSell891$20.69$18,434.79View SEC Filing  
12/9/2016Raymond BartoneInsiderSell5,000$21.54$107,700.00View SEC Filing  
12/8/2016Nicolas I ShackleyInsiderSell2,500$21.27$53,175.00View SEC Filing  
11/30/2016Frank DebenedittisInsiderSell7,040$20.22$142,348.80View SEC Filing  
11/29/2016Satish SrinivasanCOOSell12,917$20.02$258,598.34View SEC Filing  
11/28/2016Albert L EilenderChairmanSell18,500$19.88$367,780.00View SEC Filing  
11/23/2016Steven RogersSVPSell2,400$19.53$46,872.00View SEC Filing  
11/14/2016Hans C NoetzliDirectorSell6,000$18.32$109,920.00View SEC Filing  
9/8/2016Salvatore J Sr Guccione SrInsiderSell260$19.64$5,106.40View SEC Filing  
9/7/2016Charles John AlaimoInsiderSell25$19.43$485.75View SEC Filing  
9/6/2016Albert L EilenderChairmanSell12,936$19.92$257,685.12View SEC Filing  
9/6/2016Frank DebenedittisInsiderSell4,580$19.85$90,913.00View SEC Filing  
9/6/2016Satish SrinivasanCOOSell3,980$19.84$78,963.20View SEC Filing  
9/6/2016Steven RogersSVPSell2,167$20.04$43,426.68View SEC Filing  
9/2/2016Charles John AlaimoInsiderSell2,567$19.85$50,954.95View SEC Filing  
7/19/2016Satish SrinivasanCOOSell595$25.48$15,160.60View SEC Filing  
7/7/2016Frank DebenedittisVPSell3,275$23.34$76,438.50View SEC Filing  
7/6/2016Albert L EilenderChairmanSell7,690$22.53$173,255.70View SEC Filing  
7/6/2016Charles John AlaimoSVPSell3,639$22.41$81,549.99View SEC Filing  
7/6/2016Douglas A RothCFOSell6,770$22.72$153,814.40View SEC Filing  
7/6/2016Salvatore J Sr Guccione SrCEOSell10,945$23.25$254,471.25View SEC Filing  
7/6/2016Satish SrinivasanCOOSell3,250$22.80$74,100.00View SEC Filing  
7/6/2016Steven RogersVPSell3,275$22.50$73,687.50View SEC Filing  
6/7/2016Terry KippleyVPSell2,000$22.50$45,000.00View SEC Filing  
6/7/2016William N BrittonDirectorSell4,200$23.12$97,104.00View SEC Filing  
6/6/2016Frank DebenedittisVPSell6,810$22.63$154,110.30View SEC Filing  
6/6/2016Satish SrinivasanCOOSell3,497$22.69$79,346.93View SEC Filing  
5/31/2016Albert L EilenderChairmanSell9,881$22.21$219,457.01View SEC Filing  
5/26/2016Douglas A RothCFOSell7,000$22.16$155,120.00View SEC Filing  
3/10/2016Raymond BartoneSVPSell3,000$22.40$67,200.00View SEC Filing  
3/8/2016Hans C NoetzliDirectorSell6,500$22.91$148,915.00View SEC Filing  
3/2/2016Frank DebenedittisVPSell3,000$21.98$65,940.00View SEC Filing  
3/1/2016Steven RogersVPSell2,100$21.82$45,822.00View SEC Filing  
2/25/2016Albert L EilenderChairmanSell9,281$21.79$202,232.99View SEC Filing  
2/23/2016Charles John AlaimoSVPSell4,750$21.91$104,072.50View SEC Filing  
2/23/2016Douglas A RothCFOSell17,000$21.52$365,840.00View SEC Filing  
12/9/2015Satish SrinivasanCOOSell3,000$27.02$81,060.00View SEC Filing  
12/9/2015Terry KippleyVPSell1,550$27.06$41,943.00View SEC Filing  
12/8/2015Nicolas I ShackleySVPSell3,000$26.70$80,100.00View SEC Filing  
12/1/2015Charles John AlaimoSVPSell3,000$28.22$84,660.00View SEC Filing  
11/25/2015Hans C. NoetzliDirectorSell3,000$27.52$82,560.00View SEC Filing  
11/24/2015Steven RogersVPSell3,000$27.56$82,680.00View SEC Filing  
10/15/2015Albert L. EilenderChairmanSell8,155$28.90$235,679.50View SEC Filing  
9/10/2015Charles John AlaimoSVPSell1,620$22.14$35,866.80View SEC Filing  
9/10/2015Douglas A. RothCFOSell6,250$22.14$138,375.00View SEC Filing  
9/10/2015Frank DebenedittisVPSell2,553$22.14$56,523.42View SEC Filing  
9/10/2015Salvatore J. Sr Guccione, Sr.CEOSell9,386$22.14$207,806.04View SEC Filing  
7/2/2015Albert L EilenderChairmanSell10,938$24.20$264,699.60View SEC Filing  
7/2/2015Charles John AlaimoSVPSell2,998$24.19$72,521.62View SEC Filing  
7/2/2015Douglas A RothCFOSell5,748$24.19$139,044.12View SEC Filing  
7/2/2015Frank DebenedittisVPSell2,629$24.19$63,595.51View SEC Filing  
7/2/2015Salvatore J Sr Guccione SrCEOSell9,114$24.19$220,467.66View SEC Filing  
7/2/2015Satish SrinivasanCOOSell1,921$24.19$46,468.99View SEC Filing  
6/8/2015Raymond BartoneSVPSell5,000$24.44$122,200.00View SEC Filing  
6/3/2015Frank DebenedittisVPSell4,000$24.41$97,640.00View SEC Filing  
5/27/2015Charles John AlaimoSVPSell2,000$23.19$46,380.00View SEC Filing  
5/12/2015William N BrittonDirectorSell13,000$21.31$277,030.00View SEC Filing  
3/4/2015Douglas A RothCFOSell5,000$20.99$104,950.00View SEC Filing  
3/4/2015Natasha GiordanoDirectorSell2,164$20.92$45,270.88View SEC Filing  
2/12/2015Douglas A RothCFOSell6,000$19.91$119,460.00View SEC Filing  
2/10/2015Charles John AlaimoSVPSell2,000$20.15$40,300.00View SEC Filing  
12/9/2014Frank DebenedittisVPSell3,000$21.25$63,750.00View SEC Filing  
12/5/2014Douglas A RothCFOSell7,000$22.07$154,490.00View SEC Filing  
12/3/2014Terry KippleyVPSell1,950$21.35$41,632.50View SEC Filing  
12/2/2014Terry KippleyVPSell1,797$21.45$38,545.65View SEC Filing  
12/1/2014Satish SrinivasanCOOSell1,430$21.00$30,030.00View SEC Filing  
11/11/2014Charles John AlaimoSVPSell2,250$21.22$47,745.00View SEC Filing  
9/9/2014Douglas A RothCFOSell6,000$21.57$129,420.00View SEC Filing  
9/9/2014Natasha GiordanoDirectorSell1,453$21.94$31,878.82View SEC Filing  
9/9/2014Raymond BartoneSVPSell3,000$21.49$64,470.00View SEC Filing  
9/9/2014Steven RogersVPSell8,335$21.50$179,202.50View SEC Filing  
9/2/2014Albert L EilenderChairmanSell7,144$19.14$136,736.16View SEC Filing  
8/29/2014Hans C NoetzliDirectorSell2,000$18.85$37,700.00View SEC Filing  
8/15/2014Hans C NoetzliDirectorSell2,000$18.63$37,260.00View SEC Filing  
8/4/2014Albert L EilenderChairmanSell4,195$16.71$70,098.45View SEC Filing  
8/1/2014Hans C NoetzliDirectorSell2,000$16.67$33,340.00View SEC Filing  
7/25/2014Albert L EilenderChairmanSell2,450$17.63$43,193.50View SEC Filing  
7/3/2014Hans C NoetzliDirectorSell2,000$17.86$35,720.00View SEC Filing  
7/2/2014Albert L EilenderChairmanSell1,750$18.05$31,587.50View SEC Filing  
6/6/2014Charles John AlaimoSVPSell2,000$17.51$35,020.00View SEC Filing  
6/6/2014Natasha GiordanoDirectorSell1,160$17.28$20,044.80View SEC Filing  
6/6/2014Steven RogersVPSell2,333$17.58$41,014.14View SEC Filing  
6/4/2014Frank DebenedittisVPSell30,000$17.09$512,700.00View SEC Filing  
6/4/2014Nicolas I ShackleyInsiderSell1,000$17.29$17,290.00View SEC Filing  
6/2/2014Douglas A RothCFOSell6,500$17.10$111,150.00View SEC Filing  
6/2/2014Natasha GiordanoDirectorSell1,149$17.43$20,027.07View SEC Filing  
5/23/2014Natasha GiordanoDirectorSell1,128$17.91$20,202.48View SEC Filing  
5/21/2014Natasha GiordanoDirectorSell1,110$17.81$19,769.10View SEC Filing  
3/10/2014Terry KippleyVPSell3,817$19.17$73,171.89View SEC Filing  
2/14/2014Roger Weaving, Jr.SVPSell6,000$18.96$113,760.00View SEC Filing  
11/12/2013Roger Weaving, Jr.SVPSell14,605$19.03$277,933.15View SEC Filing  
9/6/2013Raymond BartoneSVPSell19,000$14.84$281,960.00View SEC Filing  
6/7/2013Roger Weaving JrVPSell4,420$13.02$57,548.40View SEC Filing  
6/6/2013Guillaume Saint-ClairVPSell15,332$13.01$199,469.32View SEC Filing  
6/4/2013Douglas A RothCFOSell30,000$13.31$399,300.00View SEC Filing  
6/4/2013Eis Jan VanDirectorSell9,000$13.39$120,510.00View SEC Filing  
5/24/2013Ronald GoldCOOSell25,000$11.71$292,750.00View SEC Filing  
5/22/2013Frank DebenedittisVPSell8,300$11.86$98,438.00View SEC Filing  
5/21/2013Frank DebenedittisVPSell7,867$12.00$94,404.00View SEC Filing  
5/17/2013Douglas A RothCFOSell20,200$11.31$228,462.00View SEC Filing  
5/17/2013Guillaume Saint-ClairVPSell2,250$11.15$25,087.50View SEC Filing  
5/15/2013Ronald GoldCOOSell55,000$11.23$617,650.00View SEC Filing  
5/14/2013David B RosenVPSell40,000$11.05$442,000.00View SEC Filing  
5/14/2013Roger Weaving JrSVPSell5,600$11.09$62,104.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Aceto Corporation (NASDAQ:ACET)
DateHeadline logoAceto Corporation (NASDAQ:ACET) Deferred Tax Assets At $2.512 Millions - (NASDAQ:ACET) - February 22 at 3:17 PM logoTop Ranked Value Stocks to Buy for February 22nd (NASDAQ:ACET) - February 22 at 11:46 AM logoTop Ranked Value Stocks to Buy for February 21st (NASDAQ:ACET) - February 21 at 3:34 PM logoAceto Shifting Its Unusual Model Toward Generics - Seeking Alpha - Seeking Alpha (NASDAQ:ACET) - February 18 at 3:16 PM logoACETO : Financial Statements and Exhibits (form 8-K/A) (NASDAQ:ACET) - February 17 at 6:48 PM logoACETO CORP Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:ACET) - February 17 at 6:48 PM logoTop Ranked Value Stocks to Buy for February 16th (NASDAQ:ACET) - February 16 at 3:19 PM logoVerdezyne Launches New Corrosion Inhibitor (NASDAQ:ACET) - February 16 at 6:17 AM
News IconPrice Index Watch on Shares of Aceto Corporation (NASDAQ:ACET) - Piedmont Register (NASDAQ:ACET) - February 14 at 8:33 PM logoETFs with exposure to Aceto Corp. : February 14, 2017 (NASDAQ:ACET) - February 14 at 3:31 PM logoNational Research Leads 'Safe' Dividend Healthcare Dogs By Yield, Aceto Leads By Gains, In February (NASDAQ:ACET) - February 11 at 3:17 PM
News IconAceto Corp ACET Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:ACET) - February 10 at 3:19 PM logoAceto (ACET) is Oversold: Can It Recover? (NASDAQ:ACET) - February 10 at 3:19 PM logoACETO CORP Financials (NASDAQ:ACET) - February 9 at 3:17 PM
News IconTop Medicine Studies of 2016 (NASDAQ:ACET) - February 7 at 8:23 PM logoTop Ranked Value Stocks to Buy for February 7th (NASDAQ:ACET) - February 7 at 3:21 PM logoAceto Corp. :ACET-US: Earnings Analysis: Q2, 2017 By the Numbers : February 7, 2017 (NASDAQ:ACET) - February 7 at 3:21 PM
News IconAceto, facing increased competition, swings to loss (NASDAQ:ACET) - February 4 at 1:27 AM
News IconAceto Corporation (ACET) Stock Is At 52-Week Low Now (NASDAQ:ACET) - February 4 at 1:27 AM logoWhy Aceto Corporation's Shares Plunged 18% Today (NASDAQ:ACET) - February 3 at 3:45 PM logoAceto Corporation 2016 Q4 - Results - Earnings Call Slides (NASDAQ:ACET) - February 3 at 3:22 PM logoAnalyst Downgrades – Aceto Corporation (NASDAQ:ACET) Stock Gets Downgraded By Craig Hallum from Buy to Hold (NASDAQ:ACET) - February 3 at 3:22 PM logoACETO CORP : Change in Directors or Principal Officers (form 8-K) (NASDAQ:ACET) - February 3 at 1:20 AM logoACETO Corp (ACET) Appoints Vimal Kavuru to the Board of Directors (NASDAQ:ACET) - February 3 at 1:20 AM logoAceto Corp. Reports 32% Retreat In Q2 Earnings (NASDAQ:ACET) - February 3 at 1:20 AM logoQ2 2017 Aceto Corp Earnings Release - After Market Close (NASDAQ:ACET) - February 2 at 8:18 PM logo5:09 pm Aceto misses by $0.08, misses on revs (NASDAQ:ACET) - February 2 at 8:18 PM logoAceto reports 2Q loss (NASDAQ:ACET) - February 2 at 8:18 PM logoAceto Corp Earnings Call (Q2 2017) (NASDAQ:ACET) - February 2 at 3:17 PM logoACETO Appoints Vimal Kavuru to the Board of Directors (NASDAQ:ACET) - February 2 at 3:17 PM logoAceto Corp. : ACET-US: Dividend Analysis : December 12th, 2016 (record date) : By the numbers : January 31, 2017 (NASDAQ:ACET) - January 31 at 3:21 PM logoFalling Earnings Estimates Signal Weakness Ahead for Eagle Pharmaceuticals (EGRX) (NASDAQ:ACET) - January 25 at 3:22 PM logoACETO Corporation Schedules Second Quarter Fiscal 2017 Financial Results News Release and Conference Call (NASDAQ:ACET) - January 24 at 3:37 PM logo4 Stocks Flaunting Low Price-to-Cash-Flow Ratio (NASDAQ:ACET) - January 19 at 3:20 PM logoAceto Corp. – Value Analysis (NASDAQ:ACET) : January 19, 2017 (NASDAQ:ACET) - January 19 at 3:20 PM logoAceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : January 18, 2017 (NASDAQ:ACET) - January 18 at 8:41 PM logoGlucuronolactone Market Intelligence Report Offers Growth Prospects (NASDAQ:ACET) - January 17 at 3:29 PM logoWill Aceto (ACET) Be a Suitable Pick for Value Investors? (NASDAQ:ACET) - January 17 at 10:21 AM
News IconReport explores the global carbendazim market (NASDAQ:ACET) - January 5 at 3:32 PM
News IconGlucuronolactone Market Revenue and Value Chain 2015-2025 (NASDAQ:ACET) - January 4 at 1:32 AM logoAceto Presents At Singular Research's Uncovered Values Webcast - Slide Show (NASDAQ:ACET) - December 26 at 3:18 PM logoACETO : Completes Acquisition of Generic Products and Related Assets of Citron Pharma and Lucid Pharma (NASDAQ:ACET) - December 22 at 3:17 PM logoBRIEF-Aceto Corp entered into a second amended credit agreement (NASDAQ:ACET) - December 22 at 3:17 PM logoACETO CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition o (NASDAQ:ACET) - December 21 at 8:33 PM logoACETO : to Participate at Upcoming Investor Conferences in January (NASDAQ:ACET) - December 21 at 3:32 PM logoACETO Completes Acquisition of Generic Products and Related Assets of Citron Pharma and Lucid Pharma (NASDAQ:ACET) - December 21 at 3:32 PM logoForm 4/A ACETO CORP For: Dec 16 Filed by: Kippley Terry (NASDAQ:ACET) - December 21 at 1:22 AM logoETFs with exposure to Aceto Corp. : December 19, 2016 (NASDAQ:ACET) - December 19 at 3:23 PM logoSome CHA Seniors Lack Heat While Waiting On New Apartments (NASDAQ:ACET) - December 16 at 3:24 PM logoACETO Comments on Legal Proceedings affecting the Generic Pharmaceuticals Industry (NASDAQ:ACET) - December 15 at 8:25 PM


What is Aceto Corporation's stock symbol?

Aceto Corporation trades on the NASDAQ under the ticker symbol "ACET."

How often does Aceto Corporation pay dividends? What is the dividend yield for Aceto Corporation?

Aceto Corporation announced a quarterly dividend on Thursday, February 2nd. Stockholders of record on Friday, March 10th will be given a dividend of $0.065 per share on Friday, March 24th. This represents a $0.26 dividend on an annualized basis and a dividend yield of 1.69%. The ex-dividend date of this dividend is Wednesday, March 8th.

Where is Aceto Corporation's stock going? Where will Aceto Corporation's stock price be in 2017?

2 analysts have issued 1 year price targets for Aceto Corporation's shares. Their predictions range from $21.00 to $21.00. On average, they expect Aceto Corporation's share price to reach $21.00 in the next year.

When will Aceto Corporation announce their earnings?

Aceto Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, May, 3rd 2017.

Who owns Aceto Corporation stock?

Aceto Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (7.25%), Royce & Associates LP (5.80%), Champlain Investment Partners LLC (4.13%), Denver Investment Advisors LLC (3.13%), State Street Corp (2.32%) and Ranger Investment Management L.P. (2.30%). Company insiders that own Aceto Corporation stock include Albert L Eilender, Charles John Alaimo, Daniel B Yarosh, Douglas A Roth, Frank Debenedittis, Hans C Noetzli, Natasha Giordano, Nicolas I Shackley, Raymond Bartone, Salvatore J Sr Guccione Sr, Salvatore J Sr Guccione, Sr, Satish Srinivasan, Steven Rogers, Terry Kippley and William N Britton.

Who sold Aceto Corporation stock? Who is selling Aceto Corporation stock?

Aceto Corporation's stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, Loomis Sayles & Co. L P, AQR Capital Management LLC, Allianz Asset Management AG, Ranger Investment Management L.P., Putnam Investments LLC, Ladenburg Thalmann Financial Services Inc. and State Board of Administration of Florida Retirement System. Company insiders that have sold Aceto Corporation stock in the last year include Albert L Eilender, Charles John Alaimo, Daniel B Yarosh, Douglas A Roth, Frank Debenedittis, Hans C Noetzli, Nicolas I Shackley, Raymond Bartone, Salvatore J Sr Guccione Sr, Satish Srinivasan, Steven Rogers, Terry Kippley and William N Britton.

Who bought Aceto Corporation stock? Who is buying Aceto Corporation stock?

Aceto Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Champlain Investment Partners LLC, Denver Investment Advisors LLC, Dimensional Fund Advisors LP, Russell Investments Group Ltd., AlphaOne Investment Services LLC, Two Sigma Investments LP, State Street Corp and Summit Global Investments.

How do I buy Aceto Corporation stock?

Shares of Aceto Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Aceto Corporation stock cost?

One share of Aceto Corporation stock can currently be purchased for approximately $15.36.

Aceto Corporation (NASDAQ:ACET) Chart for Sunday, February, 26, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Aceto Corporation (NASDAQ:ACET)

Earnings History Chart

Earnings by Quarter for Aceto Corporation (NASDAQ:ACET)

Dividend History Chart

Dividend Payments by Quarter for Aceto Corporation (NASDAQ:ACET)

Last Updated on 2/26/2017 by Staff